Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein

The interaction of the HIV-1 transactivator protein Tat with its transactivation response (TAR) RNA is an essential step in viral replication and therefore an attractive target for developing antivirals with new mechanisms of action. Numerous compounds that bind to the 3-nt bulge responsible for binding Tat have been identified in the past, but none of these molecules had sufficient potency to warrant pharmaceutical development. We have discovered conformationally-constrained cyclic peptide mimetics of Tat that are specific nM inhibitors of the Tat-TAR interaction by using a structure-based approach. The lead peptides are nearly as active as the antiviral drug nevirapine against a variety of clinical isolates in human lymphocytes. The NMR structure of a peptide–RNA complex reveals that these molecules interfere with the recruitment to TAR of both Tat and the essential cellular cofactor transcription elongation factor-b (P-TEFb) by binding simultaneously at the RNA bulge and apical loop, forming an unusually deep pocket. This structure illustrates additional principles in RNA recognition: RNA-binding molecules can achieve specificity by interacting simultaneously with multiple secondary structure elements and by inducing the formation of deep binding pockets in their targets. It also provides insight into the P-TEFb binding site and a rational basis for optimizing the promising antiviral activity observed for these cyclic peptides.

[1]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[2]  Patel,et al.  Molecular recognition in the bovine immunodeficiency virus Tat peptide-TAR RNA complex. , 1995, Chemistry & biology.

[3]  J. Karn,et al.  High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. , 1993, Journal of molecular biology.

[4]  J. Karn,et al.  An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Frankel,et al.  Dissection of the proposed base triple in human immunodeficiency virus TAR RNA indicates the importance of the Hoogsteen interaction. , 1997, Biochemistry.

[6]  John A. Robinson,et al.  TAR RNA recognition by a cyclic peptidomimetic of Tat protein. , 2005, Biochemistry.

[7]  T. Rana,et al.  Controlling human immunodeficiency virus type 1 gene expression by unnatural peptides. , 1999, Biochemistry.

[8]  J. Puglisi,et al.  Solution Structure of a Bovine Immunodeficiency Virus Tat-TAR Peptide-RNA Complex , 1995, Science.

[9]  E. De Clercq,et al.  The regulation of HIV‐1 transcription: Molecular targets for chemotherapeutic intervention , 2006, Medicinal research reviews.

[10]  J. Karn,et al.  Tackling Tat. , 1999, Journal of molecular biology.

[11]  John A. Robinson,et al.  Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodeficiency virus. , 2007, Biochemistry.

[12]  J. Puglisi,et al.  Conformation of the TAR RNA-arginine complex by NMR spectroscopy. , 1992, Science.

[13]  John A. Robinson The Design, Synthesis and Conformation of Some New β-Hairpin Mimetics: Novel Reagents for Drug and Vaccine Discovery , 2000 .

[14]  J. Karn,et al.  Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA. , 2004, Journal of molecular biology.

[15]  John A. Robinson,et al.  Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements. , 2004, Journal of the American Chemical Society.

[16]  D. Patel,et al.  Concerted motions in HIV-1 TAR RNA may allow access to bound state conformations: RNA dynamics from NMR residual dipolar couplings. , 2002, Journal of molecular biology.

[17]  B Tidor,et al.  Arginine-mediated RNA recognition: the arginine fork , 1991, Science.

[18]  A. Bax,et al.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology , 1999, Journal of biomolecular NMR.

[19]  C. A. Theimer,et al.  New applications of 2D filtered/edited NOESY for assignment and structure elucidation of RNA and RNA-protein complexes , 2004, Journal of biomolecular NMR.

[20]  J. A. Jaeger,et al.  An NMR study of the HIV-1 TAR element hairpin. , 1993, Biochemistry.

[21]  J. Karn,et al.  The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. , 1995, Journal of molecular biology.

[22]  John A. Robinson The Design, Synthesis and Conformation of Some New β-Hairpin Mimetics: Novel Reagents for Drug and Vaccine Discovery , 2000 .

[23]  Gabriele Varani,et al.  NMR investigation of RNA structure , 1996 .

[24]  A M Gronenborn,et al.  Direct structure refinement against residual dipolar couplings in the presence of rhombicity of unknown magnitude. , 1998, Journal of magnetic resonance.

[25]  M. Baba Recent status of HIV-1 gene expression inhibitors. , 2006, Antiviral research.

[26]  Christopher L. McClendon,et al.  Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.

[27]  Gabriele Varani,et al.  How binding of small molecule and peptide ligands to HIV-1 TAR alters the RNA motional landscape , 2009, Nucleic acids research.

[28]  Gabriele Varani,et al.  Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots". , 2004, Journal of molecular biology.

[29]  B. Peterlin,et al.  Controlling the elongation phase of transcription with P-TEFb. , 2006, Molecular cell.

[30]  A. Kirschning,et al.  TAR-RNA recognition by a novel cyclic aminoglycoside analogue , 2006, Nucleic acids research.

[31]  Charles D Schwieters,et al.  The Xplor-NIH NMR molecular structure determination package. , 2003, Journal of magnetic resonance.

[32]  G. Varani,et al.  Targeting RNA with small-molecule drugs: therapeutic promise and chemical challenges. , 2001, Accounts of chemical research.

[33]  J. Williamson,et al.  Solution structure of the HIV-2 TAR-argininamide complex. , 1997, Journal of molecular biology.